Here, they found that small‐molecule inhibitors of BRD4 and IRS2, in combination, mimicked the effects of the hemoglobin alpha/beta heterodimer and restricted the malignant phenotype of brain‐metastasizing melanoma cells. This evidence concerns the gene BRD4 and melanoma.